PIKfyve, a Class III Lipid Kinase, Is Required for TLR-Induced Type I IFN Production via Modulation of ATF3

Cited 25 time in webofscience Cited 0 time in scopus
  • Hit : 384
  • Download : 0
DC FieldValueLanguage
dc.contributor.authorCai, Xinmingko
dc.contributor.authorXu, Yongyaoko
dc.contributor.authorKim, You-Meko
dc.contributor.authorLoureiro, Josephko
dc.contributor.authorHuang, Qianko
dc.date.accessioned2018-03-21T02:53:51Z-
dc.date.available2018-03-21T02:53:51Z-
dc.date.created2018-03-14-
dc.date.created2018-03-14-
dc.date.issued2014-04-
dc.identifier.citationJOURNAL OF IMMUNOLOGY, v.192, no.7, pp.3383 - 3389-
dc.identifier.issn0022-1767-
dc.identifier.urihttp://hdl.handle.net/10203/240794-
dc.description.abstractType I IFN plays a key role in antiviral responses. It also has been shown that deregulation of type I IFN expression following abnormal activation of TLRs contributes to the pathogenesis of systemic lupus erythematosus. In this study, we find that PIKfyve, a class III lipid kinase, is required for endolysosomal TLR-induced expression of type I IFN in mouse and human cells. PIKfyve binds to phosphatidylinositol 3-phosphate and synthesizes phosphatidylinositol 3,5-bisphosphate, and plays a critical role in endolysosomal trafficking. However, PIKfyve modulates type I IFN production via mechanisms independent of receptor and ligand trafficking in endolysosomes. Instead, pharmacological or genetic inactivation of PIKfyve rapidly induces expression of the transcription repressor ATF3, which is necessary and sufficient for suppression of type I IFN expression by bin'ding to its promoter and blocking its transcription. Thus, we have uncovered a novel phosphoinositide-mediated regulatory mechanism that controls TLR-mediated induction of type I IFN, which may provide a new therapeutic indication for the PIKfyve inhibitor.-
dc.languageEnglish-
dc.publisherAMER ASSOC IMMUNOLOGISTS-
dc.subjectSYSTEMIC-LUPUS-ERYTHEMATOSUS-
dc.subjectACTIVATING TRANSCRIPTION FACTOR-3-
dc.subjectPHOSPHATIDYLINOSITOL 3,5-BISPHOSPHATE-
dc.subjectIL-12/IL-23 INHIBITOR-
dc.subjectINTERFERON-ALPHA-
dc.subjectPROTEIN-KINASE-
dc.subjectCPG DNA-
dc.subjectTOLL-LIKE-RECEPTOR-4-
dc.subjectNEURODEGENERATION-
dc.subjectPI(3,5)P-2-
dc.titlePIKfyve, a Class III Lipid Kinase, Is Required for TLR-Induced Type I IFN Production via Modulation of ATF3-
dc.typeArticle-
dc.identifier.wosid000333342800047-
dc.identifier.scopusid2-s2.0-84897529123-
dc.type.rimsART-
dc.citation.volume192-
dc.citation.issue7-
dc.citation.beginningpage3383-
dc.citation.endingpage3389-
dc.citation.publicationnameJOURNAL OF IMMUNOLOGY-
dc.identifier.doi10.4049/jimmunol.1302411-
dc.contributor.localauthorKim, You-Me-
dc.contributor.nonIdAuthorCai, Xinming-
dc.contributor.nonIdAuthorXu, Yongyao-
dc.contributor.nonIdAuthorLoureiro, Joseph-
dc.contributor.nonIdAuthorHuang, Qian-
dc.description.isOpenAccessN-
dc.type.journalArticleArticle-
dc.subject.keywordPlusSYSTEMIC-LUPUS-ERYTHEMATOSUS-
dc.subject.keywordPlusACTIVATING TRANSCRIPTION FACTOR-3-
dc.subject.keywordPlusPHOSPHATIDYLINOSITOL 3,5-BISPHOSPHATE-
dc.subject.keywordPlusIL-12/IL-23 INHIBITOR-
dc.subject.keywordPlusINTERFERON-ALPHA-
dc.subject.keywordPlusPROTEIN-KINASE-
dc.subject.keywordPlusCPG DNA-
dc.subject.keywordPlusTOLL-LIKE-RECEPTOR-4-
dc.subject.keywordPlusNEURODEGENERATION-
dc.subject.keywordPlusPI(3,5)P-2-
Appears in Collection
MSE-Journal Papers(저널논문)
Files in This Item
There are no files associated with this item.
This item is cited by other documents in WoS
⊙ Detail Information in WoSⓡ Click to see webofscience_button
⊙ Cited 25 items in WoS Click to see citing articles in records_button

qr_code

  • mendeley

    citeulike


rss_1.0 rss_2.0 atom_1.0